Latest news - Johnson & Johnson
Oct 24, 2024 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Johnson & Johnson (JNJ) Latest Stock News & Headlines
Get the latest Johnson & Johnson (JNJ) stock news and headlines to help you in your trading and investing decisions.
Press Releases - Johnson & Johnson
5 days ago · Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2024. Explore all Johnson & Johnson published press releases by date and/or topic of news.
J&J advances $6.475 billion settlement of talc cancer lawsuits | CNN ...
May 1, 2024 · Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause...
Johnson wins dramatic vote to remain House speaker
Jan 4, 2025 · Mike Johnson was re-elected speaker of the House on Friday after flipping two GOP opponents following an intervention by President-elect Donald Trump.
Trump Transition Updates: Mike Johnson Wins Re-election as …
Jan 4, 2025 · Speaker Mike Johnson on Friday won re-election to the top post in the House, salvaging his job in a dramatic last-minute turnabout by putting down a revolt from conservatives who initially voted...
Johnson wins dramatic reelection as speaker after 2 GOP hard ... - ABC News
Jan 4, 2025 · In some high-stakes political drama, the House of Representatives on Friday voted to reelect House Speaker Mike Johnson to lead the 119th Congress by a razor-thin margin.
Johnson & Johnson (JNJ) Stock Price, News, Quote & History
Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Johnson & Johnson | AP News - Associated Press News
Jan 23, 2024 · Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies. FDA says that decongestant in many cold medicines doesn’t work. So what does? Do I need a booster if I got the Johnson & Johnson vaccine?
News | Johnson & Johnson - Investors
Jan 10, 2025 · Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease